Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Doxil and estramustine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer clinical trial (NCT00132756). Contact the study team or your healthcare provider for specific answers.

What this study is about